Munley Law is currently reviewing cases on behalf of women who have suffered permanent hair loss after using the chemotherapy drug Taxotere. Women all over the United States have begun filing lawsuits against the makers of Taxotere for failing to warn doctors and patients about this potential side effect and for overstating the drug’s effectiveness.
Our medical malpractice and product liability lawyers have decades of experience handling complex cases like these against major pharmaceutical companies who prey on people when they are at their most vulnerable. If you or someone you love suffered permanent hair loss after receiving chemotherapy treatment, contact Munley Law for a free consultation. We never collect a fee unless we win your case. Fill out our contact form, or call (855) 866-5529.
Breast Cancer Survivors Suffer Permanent Hair Loss From Taxotere Drug
Taxotere (docetaxel) is one of two major chemotherapy drugs primarily used in the treatment of breast cancer.
Most chemotherapy drugs cause temporary hair loss, but patients are told that their hair will grow back after treatment has ended. Unfortunately, many women who took Taxotere as part of their cancer treatment have been diagnosed with permanent hair loss, or alopecia, a side-effect that was never disclosed before starting treatment. What should have been a temporary side effect for these women became a permanent disfigurement, resulting in psychological trauma, depression, and emotional scarring.
Alopecia: A condition characterized by baldness and the loss of body hair, eyebrows, and eyelashes.
Drug Makers Hid Risks from Doctors and Patients
For nearly 20 years, this product was administered to patients with no indication of the risks. According to a recently filed Taxotere lawsuit, Sanofi-Aventis, one of the world’s largest pharmaceutical companies, knew about the permanent, disfiguring side effect in Taxotere as early as 2005, but failed to warn women in the United States.
The lawsuit alleges that for years product warnings in Europe and Canada included information regarding the risk for alopecia and irreversible hair loss, but no such warnings were disclosed to American doctors and patients.
In January, 2016, prompted by the FDA, Sanofi updated its warning to indicate that some cases of irreversible hair loss associated with the use of Taxotere had been reported.
What’s worse, it appears that Sanofi-Aventis misrepresented the drug’s benefits and falsely marketed Taxotere as more effective than its cheaper counterpart, Taxol, which is not only more effective but also less toxic.
Should I File a Taxotere Lawsuit?
About 1 in 8 women in the United States will develop breast cancer over the course of a lifetime.
When pharmaceutical companies prey on sick and vulnerable people and fail to adequately warn consumers about the risks associated with their product, they must be held accountable. If you or someone you love have suffered chemo-induced alopecia, the next step is to speak with a Taxotere lawsuit lawyer.
Munley Law has spent more than 55 years building a national reputation as one of the best personal injury law firms in the country. We have been named among the nation’s Best Law Firms (U.S. News and World Report), Best Lawyers in America (Best Lawyers), and Pennsylvania Super Lawyers (Pennsylvania Magazine). Our dedicated attorneys have been listed among the Top 100 Trial Lawyers in the state (National Trial Lawyers) and are proud members of the Million Dollar Advocates Forum. For more information about our legal team, check out our attorney profiles, verdicts and settlements, or real testimonies from our past clients.
We do not collect a fee for our services unless we win benefits on your behalf, so you risk nothing by speaking to one of our highly qualified and compassionate attorneys about your potential case. Chat, email, or call us today at (855) 866-5529.